Key result
Prolonged Canadian CV wait times linked to premature death and rising costs amid capacity constraints.
Why the study?
Significant gaps and variability exist in reporting cardiovascular wait times across consultations, testing, and procedures in Canada, contributing to adverse clinical outcomes.
Addressing gaps in cardiovascular wait times in Canada requires policy actions such as systematic surveillance, performance benchmarks, and digital health initiatives to prevent downstream adverse outcomes.
Answers are grounded in this paper and cite their sources.
Identifies gaps in Canadian cardiovascular reporting; leaves open development of national wait-time surveillance policies.
Cardiovascular disease remains a leading cause of morbidity and mortality in Canada. With an aging population, the burden of cardiovascular disease is expected to increase. While national reporting exists for certain cardiac procedures, there are significant gaps and variability in the reporting of time to specialists' consultations, diagnostic testing, electrophysiology procedures, and valvular heart disease interventions. Lack of systematic surveillance strategies, formalized wait-time policies, and healthcare capacity constraints contribute to prolonged wait times in cardiovascular care in Canada. These delays contribute to downstream adverse outcomes of premature deaths, preventable hospitalizations, disease progression, and rising healthcare costs. We present key lessons from national and international healthcare initiatives in addressing wait times in cardiac care. Addressing these gaps will require policy actions such as implementation of systematic surveillance programs and performance benchmarks, digital health initiatives, and reorganization of healthcare resources.
No takes yet. Share an insight, caveat, or question.
Absher et al. (2026) conducted a review in Cardiovascular disease. Prolonged wait times in cardiovascular care was evaluated. Prolonged wait times in Canadian cardiovascular care, driven by capacity constraints and lack of surveillance, contribute to adverse outcomes including premature death and rising healthcare costs.
Synapse has enriched 10 related papers. Consider them for comparative context: